Beam Therapeutics (BEAM) Return on Invested Capital (2022 - 2025)

Beam Therapeutics (BEAM) has 4 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2025.

• Return on Invested Capital for Q1 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2025 was 0.0% (changed 0.0% YoY), and the FY2024 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.0% in Q1 2025 per BEAM's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q1 2024 and troughed at 0.01% in Q4 2024.
• A 4-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2023 and fell as far as 0 bps in 2023.
• A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then surged by 56 bps to 0.0% in 2023, then slumped by 167 bps to 0.01% in 2024, then increased by 15 bps to 0.0% in 2025.
• Business Quant data shows BEAM's Return on Invested Capital at 0.0% in Q1 2025, 0.01% in Q4 2024, and 0.0% in Q3 2024.